Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

被引：15
作者：
de Leon, Jose [1 ,2 ,3 ]
机构：
[1] Univ Kentucky, Mental Hlth Res Ctr, Eastern State Hosp, Lexington, KY 40511 USA
[2] Univ Granada, Inst Neurosci, Psychiat & Neurosci Res Grp CTS 549, Granada, Spain
[3] Univ Basque Country, Santiago Apostol Hosp, Biomed Res Ctr Mental Hlth Net CIBERSAM, Vitoria, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2015年 / 54卷 / 07期
关键词：
CYP2D6; ADOLESCENTS; CHILDREN; ADHD;
D O I：
10.1016/j.jaac.2015.04.003
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
引用
收藏
页码：532 / 534
页数：3
相关论文
共 5 条
[1]   The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19 [J].
de Leon, Jose .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) :241-245
[2]   Evidence-Based Medicine Versus Personalized Medicine Are They Enemies? [J].
de Leon, Jose .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) :153-164
[3]   The future (or lack of future) of personalized prescription in psychiatry [J].
de Leon, Jose .
PHARMACOLOGICAL RESEARCH, 2009, 59 (02) :81-89
[4]   CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD [J].
Michelson, David ;
Read, Holly A. ;
Ruff, Dustin D. ;
Witcher, Jennifer ;
Zhang, Shuyu ;
McCracken, James .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (02) :242-251
[5]   CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD [J].
Trzepacz, Paula T. ;
Williams, David W. ;
Feldman, Peter D. ;
Wrishko, Rebecca E. ;
Witcher, Jennifer W. ;
Buitelaar, Jan K. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (02) :79-86
1